Zi Yi Wan
About Zi Yi Wan
Zi Yi Wan is a Research Scientist II currently working at Lucence in Singapore, with a background in molecular biology and significant contributions to fish genetics and cancer research. He has published multiple studies in reputable journals and holds a Ph.D. from Nanyang Technological University.
Work at Lucence Health
Zi Yi Wan currently holds the position of Research Scientist II at Lucence, having joined the organization in 2021. Prior to this role, Wan served as Research Scientist I at Lucence from 2020 to 2021. In this capacity, Wan has contributed to significant research projects, including the development of a circulating tumor DNA (ctDNA) mutation-based multi-cancer early detection assay. Wan has also co-authored a study on a multi-cancer screening test for cancers prevalent in Asia, published in the Journal of Clinical Oncology in 2023.
Education and Expertise
Zi Yi Wan earned a Doctor of Philosophy (Ph.D.) in Molecular Biology from Nanyang Technological University, where studies were conducted from 2015 to 2019. Prior to this, Wan obtained a Bachelor's Degree in Life Sciences from the National University of Singapore, studying from 2009 to 2012. This educational background has equipped Wan with expertise in molecular characterization and genetic mapping, particularly in aquatic species.
Background
Before joining Lucence, Zi Yi Wan worked at Temasek Life Sciences Laboratory from 2013 to 2019. Initially, Wan served as an Assistant Research Officer for three years, followed by a role as a Junior Research Fellow for another three years. During this time, Wan engaged in various research projects, including genome-wide discovery and in silico mapping of gene-associated SNPs in Nile tilapia, and significant studies related to growth traits in tilapia.
Research Contributions
Zi Yi Wan has made notable contributions to the field of aquatic genomics. Wan participated in the genome-wide discovery of gene-related SNPs in Barramundi, resulting in a publication in Conservation Genetics Resources. Additionally, Wan has co-authored multiple studies addressing genetic resistance in Asian seabass and tilapia, with findings published in reputable journals such as Fish & Shellfish Immunology and BMC Genomics.
Publications and Collaborations
Zi Yi Wan has an active publication record, contributing to various research articles in the field of molecular biology and genetics. In 2023, Wan authored a publication in the Annals of Oncology and co-authored a study on multi-cancer screening tests in the Journal of Clinical Oncology. These publications reflect Wan's involvement in advancing research related to cancer detection and genetic resistance in aquatic species.